Phase III Study of Carboplatin and Paclitaxel With Versus Without Bevacizumab Compared to Oxaliplatin and Capecitabine With Versus Without Bevacizumab as First-Line Therapy in Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Mucinous Epithelial Ovarian or Fallopian Tube Cancer
1月 212011
